Natera Oncology

We are still reflecting on the 2024 Fort Myers Miles for Melanoma event where we supported our partners at the Melanoma Research Foundation to help raise awareness for the melanoma community. Held at JetBlue Park, it was an inspiring day as we highlighted the importance of Signatera’s ctDNA testing for monitoring melanoma recurrence and IO treatment response. Together, we’re helping to advance care and empower patients with MRD testing to make informed decisions about their health. #MilesForMelanoma #MelanomaAwareness #ctDNA #MRDTesting #IOResponseMonitoring #Natera Pictured: Kellie Burns, Weekend Anchor at WBBH-NBC 2 and event emcee, and David Geske, sr. clinical oncology specialist, representing Natera at the event.

We were honored to connect with the colorectal cancer (CRC) community at #AllyCon2024. Hearing the stories of survivors, caregivers, and advocates was truly inspiring and a testament to the resilience that defines this community. A highlight of the event was Dr. Adham Jurdi's impactful presentation, "Decoding Your Cancer: How ctDNA and MRD Can Guide Your Journey," which showcased how Natera’s innovative testing supports patients and providers in monitoring CRC recurrence and making informed treatment decisions. Thanks to the Colorectal Cancer Alliance for hosting this event. #ColorectalCancer #ctDNA #Natera

"I caught it at the molecular level, and was able to intervene with treatment." - breast cancer survivor Danielle shares how Signatera gives her confidence after diagnosis and treatment of invasive ductal carcinoma. Learn how Signatera for breast cancer can help inform decisions for your patients' care: https://ow.ly/AXUn50UAGc0

ICYMI | Watch this incredible webinar and Q+A session to learn how MRD testing in melanoma care informs patient outcomes. Ask the Expert: MRD Testing for Melanoma -- The Next Steps in Recurrence Prevention Watch here: https://ow.ly/7rOQ50Uw5SZ

Hello from #SABCS24! 👋 Swing by booth #1449 to speak to Team Natera! And don't miss the latest Signatera data in our upcoming presentations throughout the event. Pictured from left to right: David Sudyka, Lindsey Carlblom, Ryan Palusak, Christian Cockerham

It's time for the 2024 San Antonio Breast Cancer Symposium (SABCS)! Say hello to our team at booth # 1449, and don't miss our featured abstract presentations highlighting the latest Signatera data in breast cancer from our experts. “We are proud to share this new data on Signatera at SABCS that underscores our commitment to generating evidence on the clinical utility of Signatera for patients with breast cancer,” said Angel A. Rodriguez, MD, senior medical director for oncology at Natera. #Natera #Signatera #SABCS24 San Antonio Breast Cancer Symposium

Join this upcoming webinar for the opportunity to learn from an expert in melanoma research and gain firsthand insights from a patient advocate. Whether you're a healthcare professional, a patient, or a caregiver, this session will deepen your understanding of MRD testing and its potential to redefine melanoma surveillance. #MRD #Natera #Melanoma https://ow.ly/vpmY50UmNSA Melanoma Research Foundation

Hear from Alexey Aleshin, MD, GM of oncology/ECD, and chief medical officer at Natera as he presents in OncoDaily's inaugural event, Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer. https://ow.ly/HsZC50Ug3Gh #Natera #Oncology

In 2024, an estimated 234,580 Americans will be diagnosed with lung cancer. Natera stands with patients, caregivers, clinicians, researchers, and industry partners all working together to eradicate Lung cancer. #LungCancerAwareness #LCSM #LCAM

New Signatera will be presented data at the San Antonio Breast Cancer Symposium (SABCS), taking place Dec. 10-13 in San Antonio, TX. Natera and its collaborators will present a total of six abstracts. “We are proud to share this new data on Signatera at SABCS that underscores our commitment to generating evidence on the clinical utility of Signatera for patients with breast cancer,” said Angel A. Rodriguez, MD, senior medical director at Natera. Read more about these presentations below. https://ow.ly/c03i50Ug9Ji #Natera #SABCS24 #Signatera